Internal Medicine, Endocrinology, Diabetes, & Metabolism · San Antonio, TX
NPI
1952368706
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
5107 Medical Drive
San Antonio, TX, 78229
Phone (210) 614-8612
Groups this clinician bills Medicare through
Medicare paid, 2024
$482K
22,695 services
Medicare patients, 2024
967
Average age 73
Drug cost, 2024
$5.0M
13,400 prescriptions
Company payments, 2025
$20K
From 33 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by William F Trigoso was code 36415 (venipuncture blood collection), 2,080 times for 879 patients. In total William F Trigoso billed 22,695 services in 92 codes, and Medicare paid $482K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-06-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 2,080 | 879 | $5.85 | $12K |
| 99214 Office E&M - Established | Office | 2,057 | 877 | $90.14 | $185K |
| 80053 Clinical Chemistry | Office | 1,736 | 823 | $10.28 | $18K |
| 83036 Blood Count | Office | 1,445 | 675 | $9.43 | $14K |
| 84443 Clinical Chemistry | Office | 1,421 | 719 | $16.37 | $23K |
| 84439 Clinical Chemistry | Office | 1,355 | 689 | $8.77 | $12K |
| 80061 Clinical Chemistry | Office | 1,346 | 636 | $12.98 | $17K |
| 85025 Blood Count | Office | 1,203 | 638 | $7.57 | $9,106 |
| 83970 Clinical Chemistry | Office | 832 | 478 | $40.20 | $33K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 830 | 565 | $13.21 | $11K |
| 84100 Clinical Chemistry | Office | 648 | 388 | $4.62 | $2,993 |
| 82306 Clinical Chemistry | Office | 644 | 486 | $28.82 | $19K |
| 84550 Clinical Chemistry | Office | 590 | 341 | $4.40 | $2,599 |
| 95251 Test - Miscellaneous | Office | 579 | 258 | $26.78 | $16K |
| 82550 Clinical Chemistry | Office | 571 | 327 | $6.34 | $3,620 |
By year: 2022 $457K for 22,077 services; 2023 $491K for 23,084 services; 2024 $482K for 22,695 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 2,080 | 879 | $5.85 | $12K |
| 80053 Clinical Chemistry | 1,736 | 823 | $10.28 | $18K |
| 83036 Blood Count | 1,445 | 675 | $9.43 | $14K |
| 84443 Clinical Chemistry | 1,421 | 719 | $16.37 | $23K |
| 84439 Clinical Chemistry | 1,355 | 689 | $8.77 | $12K |
| 80061 Clinical Chemistry | 1,346 | 636 | $12.98 | $17K |
| 85025 Blood Count | 1,203 | 638 | $7.57 | $9,106 |
| 83970 Clinical Chemistry | 832 | 478 | $40.20 | $33K |
| 84100 Clinical Chemistry | 648 | 388 | $4.62 | $2,993 |
| 82306 Clinical Chemistry | 644 | 486 | $28.82 | $19K |
Medicare prescription drug claims, 2024
In 2024, the drug William F Trigoso prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,254 prescriptions and refills. In total William F Trigoso wrote 13,400 Medicare prescriptions that cost $5.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,254 | 3,592 | 534 | $13K |
| Atorvastatin Calcium Generic | 785 | 2,223 | 370 | $6,302 |
| Ozempic Semaglutide | 716 | 1,189 | 265 | $1.1M |
| Rosuvastatin Calcium Generic | 580 | 1,698 | 280 | $8,483 |
| Metformin Hcl Generic | 521 | 1,471 | 252 | $4,101 |
| Jardiance Empagliflozin | 470 | 1,157 | 218 | $655K |
| Amlodipine Besylate Generic | 391 | 1,121 | 173 | $2,580 |
| Mounjaro Tirzepatide | 380 | 466 | 120 | $488K |
| Metformin Hcl Er Metformin Hcl | 376 | 1,069 | 181 | $2,747 |
| Losartan Potassium Generic | 368 | 1,037 | 165 | $3,337 |
| Glimepiride Generic | 290 | 810 | 136 | $2,247 |
| Lisinopril Generic | 285 | 830 | 144 | $1,766 |
| Trulicity Dulaglutide | 243 | 338 | 89 | $328K |
| Ezetimibe Generic | 239 | 697 | 110 | $6,073 |
| V-Go 20 Sub-Q Insulin Device, 20 Unit | 219 | 235 | 63 | $121K |
Brand drugs: 4,791 claims; generic drugs: 7,586 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid William F Trigoso $20K ($20K in general payments such as food, travel and fees) from 33 companies. The largest payer was Lilly USA, LLC with $12K.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 36 | $12K |
| Medtronic, Inc. MDT | 26 | $1,236 |
| Novo Nordisk Inc NVO | 21 | $647 |
| Abbott Laboratories ABT | 18 | $620 |
| Amgen Inc. AMGN | 22 | $598 |
| Sequel Med Tech, LLC | 7 | $519 |
| Mannkind Corporation MNKD | 20 | $457 |
| Madrigal Pharmaceuticals MDGL | 8 | $357 |
| Ascensia Diabetes Care Us Inc. | 21 | $333 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 19 | $322 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.